Theratechnologies (THTX) Expected to Announce Quarterly Earnings on Wednesday

Theratechnologies (NASDAQ:THTX) is expected to be announcing its earnings results before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.05 per share and revenue of $31.73 million for the quarter.

Theratechnologies Trading Up 7.4 %

Shares of NASDAQ THTX opened at $1.75 on Monday. Theratechnologies has a twelve month low of $1.08 and a twelve month high of $2.18. The stock has a 50 day moving average of $1.70 and a two-hundred day moving average of $1.42. The stock has a market cap of $80.47 million, a P/E ratio of -17.50 and a beta of 1.26.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.